CD274 and neoplasm: This suggests that tumors with high levels of PD-L1 expression in the lungs and other primary tumor sites increase oncogenic mechanisms, making them more aggressive than tumors with negative PD-L1 expression, which lose tumor-suppressing mechanisms [61].